A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PASMCs / pulmonary artery smooth muscle cells

[Related PubMed/MEDLINE]
Total Number of Papers: 1047
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PASMCs  (>> Co-occurring Abbreviation)
Long Form:   pulmonary artery smooth muscle cells
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Aldehyde Dehydrogenase 2 (ALDH2) Elicits Protection against Pulmonary Hypertension via Inhibition of ERK1/2-Mediated Autophagy. 4-HNE, ALDH2, HPASMCs, PDGF-BB, PH, WT
2022 Alpha1B-adreneroceptor is involved in norepinephrine-induced pulmonary artery smooth muscle cell proliferation via p38 signaling. alpha1B-AR, CEC, NE, p-p38, PAH, PAT, PAVTI, PCNA, PVR, RVSP
2022 Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response. AS-IV, HPH, PH
2022 Ataxia telangiectasia mutated: The potential negative regulator in platelet-derived growth factor-BB promoted proliferation of pulmonary arterial smooth muscle cells. ATM, NOX2, PAH, PDGF, ROS
2022 Attenuating effect of magnesium on pulmonary arterial calcification in rodent models of pulmonary hypertension. ARS, MCT
2022 Calpain-1 mediates vascular remodelling and fibrosis via HIF-1α in hypoxia-induced pulmonary hypertension. HPH
2022 Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism. circRNAs, miRNAs, PAECs, PH, RBPs
2022 Coagulation-independent effects of thrombin and factor Xa: role of protease-activated receptors in pulmonary hypertension. FXa, PAH, PAR
2022 Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells. BMP, BMPR2, HPASMCs, PAH
10  2022 Decrease in LINC00963 attenuates the progression of pulmonary arterial hypertension via microRNA-328-3p/profilin 1 axis. FGF-2, HIF, miRNA, PAH, PFN1, VEGF
11  2022 Decrease in Tripartite Motif Containing 24 suppresses hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/mammalian target of rapamycin complex 1 pathway. CH-PAH, mTORC1, PAH, PAs, TRIM24
12  2022 Dexlansoprazole prevents pulmonary artery hypertension by inhibiting pulmonary artery smooth muscle cell to fibroblast transition. ELISA, MCT, PAH, PDGF-BB, RNA, RVSP, VSMC
13  2022 Dihydroartemisinin Attenuates Hypoxic Pulmonary Hypertension via the Downregulation of miR-335 Targeting Vangl2. DHA, miRNAs, PH, Vangl2
14  2022 Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels. HDL-C, PAH, XZK
15  2022 Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension. PAH, RVHI, RVP, SD
16  2022 Endothelial senescence mediates hypoxia-induced vascular remodeling by modulating PDGFB expression. alpha-SMA, ECs, IPAH, PAs, PH, SA-beta-gal
17  2022 Endothelin-1 alters BMP signaling to promote proliferation of pulmonary artery smooth muscle cells. BMP, ET-1, p38 MAPK, PAH
18  2022 Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis. PH, TAPN
19  2022 Experimental Setup for Investigation of Acute Mitochondrial Oxygen Sensing in Primary Cells. AOX, ETC
20  2022 FGF21 attenuates pulmonary arterial hypertension via downregulation of miR-130, which targets PPARγ. FGF21, PAH, PPARgamma
21  2022 FUNDC1-mediated mitophagy and HIF1α activation drives pulmonary hypertension during hypoxia. HIF1alpha, KO, PH, Tg
22  2022 HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension. PAH
23  2022 hsa_circWDR37_016 Regulates Hypoxia-Induced Proliferation of Pulmonary Arterial Smooth Muscle Cells. EdU, PAH, PASMC, qRT-PCR
24  2022 Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment. PAH, qPCR
25  2022 Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation. COPD, COX-2, CSE, mPGES-1, PG, TX
26  2022 In Vivo and Ex Vivo Experimental Approach for Studying Functional Role of Notch in Pulmonary Vascular Disease. PAH, PH
27  2022 Induction of GLI1 by miR-27b-3p/FBXW7/KLF5 pathway contributes to pulmonary arterial hypertension. ET-1, ETAR, FBXW7, GLI1, KLF5, MCT, miR, PAH
28  2022 Inhibition of KIF23 Alleviates IPAH by Targeting Pyroptosis and Proliferation of PASMCs. IPAH, PRGs
29  2022 Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration. HPASMCs, MCT, OPN, PCNA, PDGF, PH, PVR
30  2022 Integrative Proteomic and Phosphoproteomic Analyses of Hypoxia-Treated Pulmonary Artery Smooth Muscle Cells. PAH, TMT
31  2022 Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway. HPASMCs, HSP110, PH, TAZ, TEAD4, YAP
32  2022 let-7b-5p suppresses the proliferation and migration of pulmonary artery smooth muscle cells via down-regulating IGF1. PDGF, PE
33  2022 LncPTSR Triggers Vascular Remodeling in Pulmonary Hypertension by Regulating [Ca2+]i in Pulmonary Arterial Smooth Muscle Cells. lncRNA, PDGF-BB, PH, PMCA4
34  2022 LncRNA-GAS5/miR-382-3p axis inhibits pulmonary artery remodeling and promotes autophagy in chronic thromboembolic pulmonary hypertension. CCK-8, CTEPH, mPAP, PDGF-BB, qRT-PCR
35  2022 Magnolol alleviates hypoxia-induced pulmonary vascular remodeling through inhibition of phenotypic transformation in pulmonary arterial smooth muscle cells. PH
36  2022 Maresin 1 intervention reverses experimental pulmonary arterial hypertension in mice. PAH, RVD, RVSP
37  2022 Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling. HPMECs, PH
38  2022 Mesenchymal Stem Cell-derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension. EVs, MSC-NVs, MSCs, PH
39  2022 Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2. MCT, MET, PAH
40  2022 Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis. HPAH, IPAH, PDGF-BB
41  2022 MicroRNA miR-627-5p restrains pulmonary artery smooth muscle cell dysfunction by targeting MAP 2 K4 and PI3K/AKT signaling. COPD, CSE
42  2022 MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents. EVs, PH, SMC
43  2022 Microrna-486-5P Regulates Human Pulmonary Artery Smooth Muscle Cell Migration via Endothelin-1. PAH
44  2022 MicroRNAs in Pulmonary Hypertension, from Pathogenesis to Diagnosis and Treatment. PAECs, PH
45  2022 miR-485-5p alleviates obstructive sleep apnea syndrome with hypertension by inhibiting PI3K/AKT signaling pathway via downregulating HIF3A expression. CIH, OSAS, PAH
46  2022 MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension. MMP, PAH
47  2022 Mxi1-0 Promotes Hypoxic Pulmonary Hypertension Via ERK/c-Myc-dependent Proliferation of Arterial Smooth Muscle Cells. HPH, Mxi1-0, PRD
48  2022 NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification. DEGs, GEO, GO, IPAH, KEGG, PPI
49  2022 Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension. NO, PAECs, PAH, ROS
50  2022 Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways. BMPR2, EndMT, HPAECs, IL-1beta, MCT, PAH, PDGF-BB, PF, RVSP, TGF-beta
51  2022 Perinatal hypoxia aggravates occlusive pulmonary vasculopathy in SU5416/hypoxia-treated rats later in life. PAH, PVD
52  2022 Potential role of cellular senescence in pulmonary arterial hypertension. ECs, PAH, SASP
53  2022 PPARγ activation inhibits PDGF-induced pulmonary artery smooth muscle cell proliferation and migration by modulating TERT. PAH, PPARgamma, SD, siRNA, TERT
54  2022 Proteasome Inhibitors Decrease the Viability of Pulmonary Arterial Smooth Muscle Cells by Restoring Mitofusin-2 Expression under Hypoxic Conditions. Mfn2, PH
55  2022 Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension. ---
56  2022 Pyrroloquinoline quinone (PQQ) improves pulmonary hypertension by regulating mitochondrial and metabolic functions. HPASMCs, MCT, PH, PQQ, SD
57  2022 Regulatory B cells protect against chronic hypoxia-induced pulmonary hypertension by modulating the Tfh/Tfr immune balance. HPH
58  2022 RPS4XL encoded by lnc-Rps4l inhibits hypoxia-induced pyroptosis by binding HSC70 glycosylation site. GST, lncRNAs, MST, PH
59  2022 Salusin-β, a TOR2A gene product, promotes proliferation, migration, fibrosis, and calcification of smooth muscle cells and accelerates the imbalance of vasomotor function and vascular remodeling in monocrotaline-induced pulmonary hypertensive rats. ACh, MCT, PA, PH, ROS, RVSP, SNP
60  2022 Sanguinarine Reverses Pulmonary Vascular Remolding of Hypoxia-Induced PH via Survivin/HIF1α-Attenuating Kv Channels. ---
61  2022 Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho. PAH, SERT, TPH1
62  2022 Sildenafil improves pulmonary vascular remodeling in a rat model of persistent pulmonary hypertension of the newborn. PDE, PPHN
63  2022 Silencing TUFM Inhibits Development of Monocrotaline-Induced Pulmonary Hypertension by Regulating Mitochondrial Autophagy via AMPK/mTOR Signal Pathway. PAH
64  2022 SKF96365 activates calcium-sensing receptors in pulmonary arterial smooth muscle cells. IPAH, PAH
65  2022 Smooth muscle Acid-sensing ion channel 1a as a therapeutic target to reverse hypoxic pulmonary hypertension. ASIC1a, CH, ECs, SM
66  2022 Smooth muscle Rac1 contributes to pulmonary hypertension. PA, PH, RV, SMC
67  2022 SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension. HIF2A, IPAH, PH, PMVECs
68  2022 Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress. ECs, HPH, MDA, RVSP, SFN, SOD
69  2022 Targeted metabolomics combined with network pharmacology to reveal the protective role of luteolin in pulmonary arterial hypertension. PAH
70  2022 Targeted treprostinil delivery inhibits pulmonary arterial remodeling. CTGF, EE, GlcA, GLUT1, PAH, PAs, RVH, TGF-ss1, TPS
71  2022 The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11. GPX4, PAH, PVR, ROS, SLC7A11
72  2022 The Mechanism of Volatile Oil of Rhodiola tangutica against Hypoxia-Induced Pulmonary Hypertension in Rats Based on RAS Pathway. CTR, GC-MS, HE, HYP, MDA, mPAP, RVHI, SD, SOD, TEM, WB
73  2022 The MFF-SIRT1/3 axis, regulated by miR-340-5p, restores mitochondrial homeostasis of hypoxia-induced pulmonary artery smooth muscle cells. PAH
74  2022 The substitution of SERCA2 redox cysteine 674 promotes pulmonary vascular remodeling by activating IRE1α/XBP1s pathway. IRE1alpha, PH, SERCA2
75  2022 The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways. MCT, PAH
76  2022 Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice. BW, HFD, PH, PH-LHD, RVSP, SGLT2, TAC, TOFO
77  2022 Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation. AIF, PH
78  2022 Upregulated ClC3 channels/transporters elicit swelling-activated Cl- currents and induce excessive cell proliferation in idiopathic pulmonary arterial hypertension. DIDS, IPAH, PAH
79  2022 Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension. PH, RVSP, sham, TEAD4, YAP
80  2022 Vascular peroxidase 1 promotes phenotypic transformation of pulmonary artery smooth muscle cells via ERK pathway in hypoxia-induced pulmonary hypertensive rats. EdU, HOCl, PAH, SD, VPO1, VPO1 siRNA
81  2022 [Effects of GW501516 on the proliferation of pulmonary artery smooth muscle cells induced by hypoxia and its mechanisms]. GSK-3beta, PPARdelta, RT-PCR
82  2022 [Effects of typical PKC subtypes on the proliferation of mouse pulmonary artery smooth muscle cells and the expression of ERK1/2 and Akt induced by hypoxia]. cPKCs, HPH
83  2022 [Salidroside inhibits phenotypic transformation of rat pulmonary artery smooth muscle cells induced by hypoxia]. alpha-SMA, CCK-8, EdU, PCNA, qRT-PCR, SM22
84  2022 [Umbelliferone improves chronic hypoxia-induced pulmonary hypertension by inhibiting the RhoA/ROCK signaling pathway and autophagy]. alpha-SMA, RV, SD, Umb
85  2021 A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature. FAK, MMP-8, PAH, PH, TAZ, YAP
86  2021 Acetazolamide prevents hypoxia-induced reactive oxygen species generation and calcium release in pulmonary arterial smooth muscle. ---
87  2021 Acid-sensing ion channel 1 contributes to pulmonary arterial smooth muscle cell depolarization following hypoxic pulmonary hypertension. ASIC1, CH, NSCC
88  2021 Activation of AMPK inhibits Galectin-3-induced pulmonary artery smooth muscle cells proliferation by upregulating hippo signaling effector YAP. FOXM1, Gal-3, PAH, siRNA, YAP
89  2021 Adenylate Kinase 4-A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1alpha Signaling Pathways. AK4, Akt, HIF-1alpha, IPAH, PH
90  2021 Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active. AOX, cmRNA, iMEFs
91  2021 An Overview of miRNAs Involved in PASMC Phenotypic Switching in Pulmonary Hypertension. miRNAs, PH
92  2021 Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling. ANDRO, BMPR2, NOX, Nrf2, PAs, PH, ROS
93  2021 Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration. CR, CYP1B1, NOX4, PAH
94  2021 Bortezomib Inhibits Hypoxia-Induced Proliferation by Suppressing Caveolin-1/SOCE/[Ca2+]i Signaling Axis in Human PASMCs. BTZ, CHX, HPH, SOCE
95  2021 Calcium-sensing receptor in the development and treatment of pulmonary hypertension. CaSR, PH
96  2021 Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function. CBD, PAH
97  2021 CENPE contributes to pulmonary vascular remodeling in pulmonary hypertension. CENP-E, PH
98  2021 Chronic hypoxia promoted pulmonary arterial smooth muscle cells proliferation through upregulated calcium-sensing receptorcanonical transient receptor potential 1/6 pathway. CaSR, CH, TRPC
99  2021 Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice. CNH, PH, STAT3, VGLL4
100  2021 Curcumin Improves Pulmonary Hypertension Rats by Regulating Mitochondrial Function. MCT, PAH